Naba Alsaha Medical Services Company
TADAWUL:9546.SR
79.2 (SAR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
2023 | 2022 | 2021 | 2020 | |
---|---|---|---|---|
Operating Activities: | ||||
Net Income
| 52.382 | 28.934 | 27.528 | 26.653 |
Depreciation & Amortization
| 9.494 | 6.765 | 6.122 | 6.09 |
Deferred Income Tax
| 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 |
Change In Working Capital
| -26.039 | -1.834 | -2.71 | -30.165 |
Accounts Receivables
| -51.505 | 1.677 | -1.127 | -29.245 |
Inventory
| -4.49 | 0.263 | -0.786 | -0.607 |
Accounts Payables
| 17.149 | -2.08 | 2.421 | -1.027 |
Other Working Capital
| 12.806 | -1.695 | -3.218 | 0.714 |
Other Non Cash Items
| -6.48 | 1.635 | -0.202 | 46.518 |
Operating Cash Flow
| 29.358 | 35.501 | 30.738 | 6.036 |
Investing Activities: | ||||
Investments In Property Plant And Equipment
| -38.866 | -11.054 | -10.365 | -39.639 |
Acquisitions Net
| -18.11 | -2.829 | 0 | 0 |
Purchases Of Investments
| -1 | -2.829 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 |
Other Investing Activites
| -2.638 | 2.829 | 0 | 0 |
Investing Cash Flow
| -60.614 | -13.883 | -10.365 | -39.639 |
Financing Activities: | ||||
Debt Repayment
| 27.063 | 0 | 0 | 0 |
Common Stock Issued
| 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 |
Dividends Paid
| -2.1 | -2.1 | 0 | -1.75 |
Other Financing Activities
| -1.788 | -1.685 | -1.685 | 34.827 |
Financing Cash Flow
| 23.175 | -14.785 | -15.165 | 31.392 |
Other Information: | ||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 3.997 |
Net Change In Cash
| -8.081 | 6.832 | 5.208 | -2.211 |
Cash At End Of Period
| 5.746 | 13.826 | 6.994 | 1.786 |